ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Ticker Update

Updates

SUB-TYPE: CLASS 3 RECALL

21st April 2016

Class 3 Drug Alert (Action Within 5 Days) Taxotere Concentrate 80mg per 4ml

Sanofi are recalling the listed batches of Taxotere (Docetaxel) Concentrate due to a production fault potentially leading to an increase in the concentration of Docetaxel in the solution.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
3556727Taxotere (Docetaxel) Concentrate for Solution for Infusion, 80mg per 4mlSanofi UK5F219A

Company contact for all enquiries: Sanofi Medical Information Department on Tel: 0845 3727101 or Email: UK-Medicalinformation@sanofi.com

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 3 RECALL

23rd March 2016

Class 3 Drug Alert (Action Within 5 Days) Algivon Alg Strl Drsg 10cmsq X 5

Advancis Medical Ltd are recalling the below batch due to the potential packaging integrity.

Please visit the GOV.UK drug alert link: N/A

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
3193703Algivon Alg Strl Drsg 10cmsq X 5Advancis MedicalWO013976

Action:

1. Contact our sales team (inese.haqure@brightwake.cauk) to request a Return Goods Number (RGN) so that we can reconcile and replace all potentially affected product.

2. Please return the affected product listed above to receive replacement.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

16th March 2016

Class 4 Drug Alert (Caution in use only) Convulex 500mg Capusles

G.L. Pharma GmbH would like to inform Healthcare professionals that they are aware that there is an error on the carton for batches 5E048A and 5H155A in relation to the strength. Inadvertently, the information "Each capsule contains 150 mg valproic acid." was printed on one side of the cartons instead of the correct "Each capsule contains 500 mg valproic acid." All other information, especially the main headings on the package ("Convulex® capsules 500 mg"), however is correct on the carton. G.L. Pharma GmbH confirms that capsules are 500mg strength. The correct strength is also given on the primary blister pack and the patient information leaflet. G.L. Pharma GmbH have informed the MHRA and the MHRA have approved the continued distribution of batches 5E048A and 5H155A until replacement stock is available.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batches
0560656Convulex 500mg CapuslesPfizer Ltd5E048A
5H155A

SUB-TYPE: COMPANY-LED RECALL

01st February 2016

Company-Led Dotarem Solution for Injection 15ml

GUERBERT have issued a precautionary recall because a glass particle has been identified in one syringe from this batch..

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
Alliance Healthcare Do Not StockDotarem Solution for Injection 15mlGuerbert9263

For further stock enquiries please contact Guerbet Sales Department on 0121 7338542.
 

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

22nd December 2015

Company-Led Drug Alert Fludarabine 25mg/ml, 1 x 2ml

Sandoz is recalling this batch because particulate matter, believed to be intrinsic to the active pharmaceutical ingredient, was identified in samples.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
Alliance Do Not StockFludarabine 25mg/ml, 1 x 2mlSandoz LtdER 4824

Alliance Healthcare do not stock and therefore we are not accepting stock returns.

Please contact Sandoz Customer Services for all enquiries relating to the issue on Telephone: 01276 698607
 

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

09th December 2015

Class 4 Drug Alert (Caution in use only) Genotropin Goquick 5.3mg and Genotropin Goquick 12mg

Pfizer Limited has notified us of a manufacturing defect in the dosing mechanism of some Genotropin GoQuick pens which are used to administer somatropin.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
3568979Genotropin Goquick 12mgPfizer LtdAll unexpired batches
3568961Genotropin Goquick 5.3mgPfizer LtdAll unexpired batches

This is a caution in use only and therefore we are not accepting stock returns.
 

Please contact Pfizer's endocrine helpline, tel 0800 521249; email endocrinecare@pfizer.com

Alternatively contact Pfizer Medical Information, tel 01304 616161
 

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

04th December 2015

Company-Led Drug Alert Pioglitazone Accord 30mg Tablets

Accord Healthcare Limited is recalling a specific batch which has inadvertently been distributed in the UK, because it is labelled for the Portuguese market.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
Alliance Do Not StockPioglitazone Accord 30mg TabletsAccord Healthcare LimitedP05615

Alliance Healthcare do not stock and therefore we are not accepting stock returns.

For stock enquiries, please contact Accord Healthcare Limited on 020 8939 3490

For Customer Services enquiries, please contact Accord Healthcare Limited on 020 8901 3507 / 020 8863 1427

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

20th May 2015

Company-Led Drug Alert Ambre Solaire

Garnier is recalling the above products of Ambre Solaire to patient level due to a 'Label Misprint'.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batches
3135522Ambre sol clr prot spry f20 200mlGarnierAll Batches
3135548Ambre sol clr prot spry f30 200mlGarnierAll Batches
3432903Ambre sol lght&slk milk spf** 200mlGarnierAll Batches
3432879Ambre sol lght&slk milk spf30 200mlGarnierAll Batches
3681285Ambre sol milk spf30 50mlGarnierAll Batches
3263555Ambre solaire kids spray spf 50 200mlGarnierAll Batches
3135506Ambre sol clr prot spry** f10 200mlGarnierAll Batches
3429370Ambre sol kids rapido sprspf30 150mlGarnierAll Batches

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 3 RECALL

24th April 2015

Class 3 Drug Alert (action within 5 days) Exocin 3mg/ml Eye Drops (1 X 5ml)

Allergan UK Limited is recalling 'Danish Language Packs' of the above batch which have been shipped to the UK in error along with UK packs with the same batch number.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
0861989Exocin 3mg/ml Eye DropsAllergan LtdE75048
8076556PI Exocin 3mg/ml Eye DropsAllergan LtdE75048

For stock control enquiries please contact Allergan Customer Services Team on 0800 3767975
 

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

02nd April 2015

Class 4 Drug Alert (Caution in use only) Epilim 200 & 500mg And Sodium Valproate

Sanofi UK have been made aware of an unusual odour associated with the above batches of Epilim / Sodium Valproate Gastro-resistant tablets. The odour has variously been described as ‘fishy', ‘sweaty armpits' and ‘cannabis'. An investigation by Sanofi has identified the root cause as the aluminium foil used in the packaging of affected batches. No impact on the quality or efficacy of the tablets has been detected. Sanofi has now ceased using this foil supplier.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batches

0269803Epilim Ec Tab 200mgSanofi UKJ601
J602
J603
K1
K2
K3
K7

0173534Epilim Ec Tab 500mgSanofi UKJ602
J603
K1
K2

Alliance do not stockSodium Val Tab 200mgZentivaK1

Alliance do not stockSodium Val Tab 500mgZentivaJ601

For all enquiries about this matter, please contact Sanofi Medical Information on 0845 3727101 or email UK-medicalinformation@sanofi.com 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.